Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous NY-ESO-1-specific CD8-positive T cells |
Trade Name | |
Synonyms | Autologous NY-ESO-1-specific CD8+ T lymphocytes |
Drug Descriptions |
Autologous NY-ESO-1-specific CD8-positive T lymphocytes are CD8-expressing T-cells that recognize the tumor antigen NY-ESO-1, which are isolated from patients and expanded for reintroduction (PMID: 25317334). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C118790 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Autologous NY-ESO-1-specific CD8-positive T cells | Autologous NY-ESO-1-specific CD8-positive T cells | 0 | 1 |